Affiliations: | 2008 | Microbiology and Immunology | Temple University, Philadelphia, PA, United States |
Area:
Immunology
We are testing a new system for linking grants to scientists.
The funding information displayed below comes from the
NIH Research Portfolio Online Reporting Tools and the
NSF Award Database.
The grant data on this page is limited to grants awarded in the United States and is thus partial. It can nonetheless be used to understand how funding patterns influence mentorship networks and vice-versa, which has deep implications on how research is done.
You can help! If you notice any innacuracies, please
sign in and mark grants as correct or incorrect matches.
Sign in to see low-probability grants and correct any errors in linkage between grants and researchers.
High-probability grants
According to our matching algorithm, Adaobi I. Nwaneshiudu is the likely recipient of the following grants.
Years |
Recipients |
Code |
Title / Keywords |
Matching score |
2006 — 2008 |
Nwaneshiudu, Adaobi I |
F31Activity Code Description: To provide predoctoral individuals with supervised research training in specified health and health-related areas leading toward the research degree (e.g., Ph.D.). |
Minority Predoctoral Fellowship Program
DESCRIPTION (provided by applicant): Systemic Sclerosis (SSc) is a disease of unknown etiology characterized by fibrosis, small vessel fibrointimal proliferation, and autoantibody production; all possibly resulting from involvement of T-cells. Organ complications can be extensive, significantly increasing morbidity and mortality. Previous studies from our laboratory show evidence of oligoclonal T-cells proliferation in the skin and peripheral blood of SSc patients, in response to currently unidentified antigens. Putative antigens include microchimeric cells, CMV and DNA topoisomerase-l. The project aims to determine the specific role(s) T-cells play in SSc pathogenesis, and potential predictor molecular signatures that predispose patients to the complications of the disease. Specific aims are to, 1)-determine the origin of clonally-expanded gamma/delta T-cells, using in-situ hybridization; 2)- identify antigens recognized by these clonally-expanded T-cells in skin biopsies and peripheral blood samples from maternal and offspring SSc patients, via transducing full-length TCR chain transcripts into beta chain TCR-negative mutant Jurkat T-cells or delta-chain TCR-negative mutant MOLT-13 T-cells and other appropriate cell lines; 3)-Use DNA microarray to assess risks for complications; and relate to sex and race.
|
1 |